Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%

Adverse effects ‐ respiratory ‐ airway obstruction · acute psychosis

Droperidol showed no clear difference in adverse effects ‐ respiratory ‐ airway obstruction compared with midazolam (low certainty).

1 finding from 1 review

Droperidol for psychosis‐induced aggression or agitation 2016 · Cochrane Headline outcomes only
RR 0.13 [0.01, 2.55]
1 study · 153 participants
Low

Adverse effects ‐ respiratory ‐ airway obstruction · acute psychosis

Droperidol showed no clear difference in adverse effects ‐ respiratory ‐ airway obstruction compared with olanzapine (low certainty).

1 finding from 1 review

Droperidol for psychosis‐induced aggression or agitation 2016 · Cochrane Headline outcomes only
RR 0.97 [0.2, 4.72]
1 study · 221 participants
Low

Adverse effects ‐ respiratory ‐ airway obstruction · acute psychosis

Droperidol showed no clear difference in adverse effects ‐ respiratory ‐ airway obstruction compared with placebo (low certainty).

1 finding from 1 review

Droperidol for psychosis‐induced aggression or agitation 2016 · Cochrane Headline outcomes only
RR 0.62 [0.15, 2.52]
1 study · 227 participants
Low